ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
暂无分享，去创建一个
M. Robinson | V. Velcheti | C. Sanders | E. Hill | Jeffrey S. Miller | J. Wrangle | H. Wong | C. Krieg | E. Garrett-Mayer | J. Ravenel | E. Yusko | J. Rytlewski | M. Rubinstein | William L. Redmond | Emily K. Jeng | M. Swiderska-syn | Amy M Sion | Andie R Edwards | C. Sherman | A. Rock | P. Rhode | J. Egan | M. Patel | M. Taffaro-Neskey | Samantha Suriano | Kate Anderton | Kathryn G Lindsey | M. Farhad | J. Harris | John M. Wrangle